Resident
QI Project 2016-17
Goal: Give ≥ 2 anti-emetics
to every eligible patient
PONV RISK ASSESSMENT
with Apfel score 3 or 4
PONV RISK ASSESSMENT
Anti-Emetics Dose Mechanism Major Side Effects Use with Caution for Patients with: Acquisition Cost
PreOp
Scopolamine 1 patch Muscarinic antagonist Anticholinergic, CNS depression Frail patients, Age >65yo $16.54/patch
Aprepitant 40mg PO Substance P/NK1 receptor antagonist None Hepatic insufficiency $83.09/40mg tab
After Induction
Dexamethasone 4mg IV Centrally acting anti-inflammatory Infection risk, Hyperglycemia, GI bleed Diabetes, Sepsis, Bone fusion cases $0.16/20mg vial
Diphenhydramine 25-50mg IV Histamine antagonist CNS depression Frail patients, Age >65yo $0.55/50mg vial
Hydroxyzine 25mg IM Histamine antagonist QT prolongation, CNS depression Frail patients, Age >65yo $3.01/25mg vial
Ephedrine 25mg IM Mechanism unknown None MAO-I/TCA/SNRI use $11.45/50mg vial
Prior to end of surgery
Ondansetron 4 mg IV 5-HT3 antagonist QT prolongation, Serotonin syndrome Hepatic insufficiency $1.21/4mg vial
Parkinson, Antipsychotic use, Frail patients, Age
Prochlorperazine 5-10 mg IV D1+D2 antagonist, Histamine antagonist Anticholinergic, Extrapyramidal, CNS depression >65yo $10.79/10mg vial
Impaired GI motility, Pheo, Seizure disorder,
Metoclopramide 20 mg IV Dopamine antagonist QT prolongation, CNS depression, Extrapyramidal Antipsychotic use $0.77/10mg vial
Haloperidol 1 mg IV/IM Dopamine antagonist Extrapyramidal, CNS depression Parkinson, Antipsychotic use $5.55/5mg vial